To date, name brand manufacturers of FDA-approved GLP-1 drugs have not appeared to target compounding pharmacies with patent infringement lawsuits, choosing instead to litigate other claims against these entities, as discussed in more detail above
Contributed by Akshi Seem, Associate Partner Read More: #PatentLaw #DelhiHighCourt #AccessToMedicine #Pharma #IntellectualProperty #MaheshwariAndCo To view or add a comment, sign in CANADA APPROVES NEW PATENT The Canadian Intellectual Property Office / Office de la proprit intellectuelle du Canada (CIPO) has granted Palisade Bio a patent for its PALI-2108 therapy, a gut-targeted PDE4 B/D inhibitor being developed for ulcerative colitis (UC) and fibrostenotic Crohns disease (FSCD)
This helps regulate appetite, slow down stomach emptying so you feel fuller longer, and improve how your body handles sugar
Current evidence doesnt show that menopausal hormone therapy reduces the effectiveness of GLP-1 medications or vice versa
Lipo-C is a specialized compound formulated to aid in the breakdown and metabolism of body fat
